All papers, including those invited by the Editor, are subject to peer review. Manuscripts are reviewed by at least two external experts and editors. The Clinical Transplantation and Research (CTR)’s average turnaround time from submission to initial decision is 4 weeks. The editor is responsible for the final decision whether the manuscript is accepted or rejected.
CTR adopts double-blind review, which means that the reviewers do not know the identity of the authors, and vice versa.
Arnetta Naomi Louise Lalisang, Afid Brilliana Putra, Nathaniel Jason Zacharia, Vania Myralda Giamour Marbun, Lam Sihardo, Ridho Ardhi Syaiful, Febiansyah Ibrahim, Wifanto Saditya Jeo, Yarman Mazni, Agi Satria Putranto, Toar Jean Maurice Lalisang
Korean J Transplant 2023;37(3): 179-188
https://doi.org/10.4285/kjt.23.0030
+ moreJin-Myung Kim, Hye Eun Kwon, Youngmin Ko, Joo Hee Jung, Hyunwook Kwon, Young Hoon Kim, Eun Key Kim, Sung Shin
Korean J Transplant 2023;37(3): 210-215
https://doi.org/10.4285/kjt.23.0021
+ moreSanghoon Lee, Suk-Koo Lee
J Korean Soc Transplant 2019;33(1): 1-5
https://doi.org/10.4285/jkstn.2019.33.1.1
+ moreHyeyoung Lee, Eun-Jee Oh
J Korean Soc Transplant 2019;33(1): 6-12
https://doi.org/10.4285/jkstn.2019.33.1.6
+ more